A new report has been published and released in November 2013.Price $2,776-00 for 240 pages.Details can be viewed at
http://www.prnewswire.com/news-releases/translational-regenerative-medicine-market-prospects-2014-2024-238872161.html
AVH and their technologies have been covered along with a number of other leaders in the stemcell and regenerative medicine field.No doubt the study is comprehensive and valuable to any large portfolio bio holders but out of my league .Good luck to anyone who could make use of the information.
for investors who feel wealthy
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.82 |
Change
0.140(3.80%) |
Mkt cap ! $266.9M | |||
| Open | High | Low | Value | Volume |
| $3.83 | $3.87 | $3.77 | $1.433M | 374.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3987 | $3.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.86 | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |